Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Andrew D Hershey"'
Publikováno v:
Cephalalgia Reports, Vol 5 (2022)
Background: Nummular headache is a rare primary headache disorder potentially disabling and refractory to treatment. Of over 300 reported cases, only 9 are children. Design/Methods: We searched our institutional database and PubMed for “nummular he
Externí odkaz:
https://doaj.org/article/d6fe043ce1ad4334be7b0307a1398d42
Autor:
Jing Xiang, Xinyao Degrauw, Abraham M Korman, Janelle R Allen, Hope L O'Brien, Marielle A Kabbouche, Scott W Powers, Andrew D Hershey
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83669 (2013)
The cerebral cortex serves a primary role in the pathogenesis of migraine. This aberrant brain activation in migraine can be noninvasively detected with magnetoencephalography (MEG). The objective of this study was to investigate the differences in m
Externí odkaz:
https://doaj.org/article/5973de8323504598b07a3bc7a1d18fa5
Autor:
Xinyao Guo, Jing Xiang, Yingying Wang, Hope O'Brien, Marielle Kabbouche, Paul Horn, Scott W Powers, Andrew D Hershey
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e50095 (2012)
Migraine attacks have been shown to interfere with normal function in the brain such as motor or sensory function. However, to date, there has been no clinical neurophysiology study focusing on the motor function in children with migraine during head
Externí odkaz:
https://doaj.org/article/a2323cc6b7fa4fb4ab79e99444221d6f
Autor:
Andrew D. Hershey, Gabriel Paiva da Silva Lima, Nicola Pannacciulli, Mia Mackowski, Reija Koukakis, Jennifer Williams McVige
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 3, Pp n/a-n/a (2024)
Abstract Erenumab, a fully human monoclonal antibody targeting the calcitonin gene‐related peptide receptor, is efficacious and safe for prevention of attacks of migraine in adults. This phase I, randomized, open‐label, multiple‐dose study eval
Externí odkaz:
https://doaj.org/article/c293b63db7ac48dbb3a15686ef74069e
Autor:
Danielle J. Kellier, Blanca Marquez de Prado, Dana Haagen, Philip Grabner, Nichelle Raj, Lara Lechtenberg, Gerardo Velasquez, Jesse Y. Hsu, John T. Farrar, Andrew D. Hershey, Christina L. Szperka
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:634-641
Autor:
Danielle J Kellier, Blanca Marquez de Prado, Dana Haagen, Philip Grabner, Nichelle R Raj, Lara Lechtenberg, Gerardo Velasquez, Jesse Y Hsu, John T Farrar, Andrew D Hershey, Christina L Szperka
Publikováno v:
Cephalalgia. 42:1013-1021
Background International guidelines recommend diaries in migraine trials for prospective collection of headache symptoms. Studies in other patient populations suggest higher adherence with electronic diaries instead of pen-and-paper. This study exami
Autor:
Robert C. Gibler, James L. Peugh, Christopher S. Coffey, Leigh Ann Chamberlin, Dixie Ecklund, Elizabeth Klingner, Jon Yankey, Leslie L. Korbee, Marielle Kabbouche, Joanne Kacperski, Linda L. Porter, Brooke L. Reidy, Andrew D. Hershey, Scott W. Powers
Publikováno v:
Headache: The Journal of Head and Face Pain.
Publikováno v:
Cephalalgia
Objective To compare clinical features in youth with continuous headache from migraine, persistent post-traumatic headache, and new daily persistent headache to determine if they are similar, contrary to their distinction in the International Classif
Autor:
Joanne Kacperski, Jon W. Yankey, Leslie L. Korbee, Christopher S. Coffey, James Peugh, Dixie Ecklund, Marielle A. Kabbouche, Andrew D. Hershey, Scott W. Powers, Elizabeth A. Klingner, Leigh A. Chamberlin, Linda Porter, Brooke L Reidy
Publikováno v:
Cephalalgia. 42:44-52
Objective Identify preventive medication treatment response trajectories among youth participating in the Childhood and Adolescent Migraine Prevention study. Methods Data were evaluated from 328 youth (ages 8–17). Childhood and Adolescent Migraine
Publikováno v:
Cephalalgia. 43:033310242311782
Background Recent experience in designing and running clinical trials on new medications for the prevention of migraine in children and adolescents highlighted the need for revision of the 1st edition of the International Headache Society Guidelines